NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in NeuroPace Inc as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q1 2023
- Shares held
- 17.5M
- −166.6K (−0.9%) vs. Q1 2023
- Total value
- $78.6M
- −$3.40M (−4.1%) vs. Q1 2023
- New holders
- 1
- 8 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $405.9M |
| Q3 2025 | 80 | $267.5M |
| Q2 2025 | 99 | $250.7M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.5M |
| Q3 2024 | 48 | $103.1M |
| Q2 2024 | 51 | $109.1M |
| Q1 2024 | 54 | $176.4M |
| Q4 2023 | 41 | $130.8M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $82.0M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 90 | $404 | 0.00% | −694−88.5% | Reduced |
| Barclays PLC | 118 | $530 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 223 | $1.00K | 0.00% | +4+1.8% | Added |
| BerganKDV Wealth Management, LLC | 420 | $1.89K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 341 | $2.00K | 0.00% | +341 | New |
| Bank of America Corp | 5,500 | $24.7K | 0.00% | −7,516−57.7% | Reduced |
| Financial Advocates Investment Management | 10,000 | $44.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 16,106 | $72.3K | 0.00% | −65−0.4% | Reduced |
| Renaissance Technologies LLC | 17,300 | $78.0K | 0.00% | +2,800+19.3% | Added |
| State Street Corp | 22,451 | $100.8K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 36,117 | $162.2K | 0.00% | +3,646+11.2% | Added |
| Bridgeway Capital Management, LLC | 60,048 | $269.6K | 0.01% | +8,400+16.3% | Added |
| Geode Capital Management, LLC | 71,515 | $321.1K | 0.00% | 00.0% | Unchanged |
| Kent Lake Capital LLC | 149,205 | $669.9K | 0.31% | +21,529+16.9% | Added |
| Vanguard Group Inc | 378,187 | $1.70M | 0.00% | +81,639+27.5% | Added |
| Nantahala Capital Management, LLC | 424,850 | $1.91M | 0.23% | −1,075−0.3% | Reduced |
| Millennium Management LLC | 628,933 | $2.82M | 0.00% | −102,677−14.0% | Reduced |
| FMR LLC | 1,223,663 | $5.49M | 0.00% | −269,268−18.0% | Reduced |
| Morgan Stanley | 2,358,866 | $10.6M | 0.00% | +100,850+4.5% | Added |
| Soleus Capital Management, L.P. | 2,466,214 | $11.1M | 1.23% | +37,500+1.5% | Added |
| OrbiMed Advisors LLC | 4,012,281 | $18.0M | 0.35% | 00.0% | Unchanged |
| KCK Ltd. | 5,621,111 | $25.2M | 39.57% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −25,388−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,052−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,623−100.0% | Sold out |